Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Tesla’s Rally Setup Is Here—But Valuation Makes It Fragile

Tesla is bouncing hard off key support and indicators are turning bullish. But a broken uptrend means this rebound must continue to gain momentum.

META Resets Reality Labs, Grows Message Sales as Ad Engine Roars

META Resets Reality Labs, Grows Message Sales as Ad Engine Roars

As Meta's advertising business booms, the company buys itself time to further AI monetization through glasses, business messaging, and Manus.

It's Not Too Late to Buy These 2 Red-Hot AI Infrastructure Stocks

It's Not Too Late to Buy These 2 Red-Hot AI Infrastructure Stocks

AI infrastructure stocks are dramatically outperforming, fueled by hyperscaler data center buildouts and surging demand for optical networking equipment.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is AI Really Eating Software? A Wall Street Veteran Says No—Here’s Why

Mark Chaikin explains why he wouldn’t buy the dip in software yet and highlights three AI infrastructure stocks he likes: Onto Innovation, Amkor Technology, and Enphase.

Grab’s 2026 Selloff Had Reasons—But the Rebound Case Is Building

Grab's stock is deeply undervalued and ready to rebound as growth and profitability outweigh near-term risks. Analysts and institutional data are bullish.

Kroger’s New CEO: A Turnaround Play in Aisle 4?

The appointment of a seasoned retail operator signals a strategic pivot toward operational efficiency and improved profitability for the grocery giant.

The Last 2 Times Amazon’s RSI Did This, the Stock Rallied 60%

Amazon’s RSI has slipped into extremely oversold territory, a setup that has previously preceded 60% rallies and could again offer serious upside from here.

inkl

Read news from The Economist, FT, and more,
with one subscription

From a Dividend King to FinTech, These 3 Large Caps Just Reported

From a Dividend King to FinTech, These 3 Large Caps Just Reported

With the market nearly flat after 28 trading days, three companies that reported on Feb. 10 provided investors with attractive guidance.

Unity’s Stock Plunges 30%: Panic? Or Profit?

Unity’s Stock Plunges 30%: Panic? Or Profit?

Investors are overlooking record cash flow and improved profitability as the company transitions to its new artificial intelligence platform.

Guidance, Not Earnings, Sends Equinix Stock Higher

Guidance, Not Earnings, Sends Equinix Stock Higher

EQIX stock surged after strong 2026 guidance highlighted accelerating AI-driven data center demand, reinforcing its role as a critical hub in AI infrastructure

Why Robinhood's Nearly 50% Slide Is a Buy-the-Dip Opportunity

Why Robinhood's Nearly 50% Slide Is a Buy-the-Dip Opportunity

With shares of Robinhood Markets down almost 50% from highs, Wall Street analysts are eyeing a significant rebound going forward.

Is Albemarle Setting Up for a Lithium-Fueled Rebound?

Is Albemarle Setting Up for a Lithium-Fueled Rebound?

Albemarle stock dipped after earnings, but rising lithium demand, particularly from AI-driven power needs could create a compelling long-term entry point

4 Reasons Fortinet Could Be at a Buyable Bottom

4 Reasons Fortinet Could Be at a Buyable Bottom

Fortinet is trading at a buyable bottom, as its results are better than expected, analyst sentiment is supportive, and institutions are accumulating.

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

Get all your
news in one place.

100's of premium titles.
One news app.

Exelixis Reports Solid Earnings—Are New Highs Back on the Table?

Exelixis beats earnings estimates as Cabometyx drives profits and zanzalintinib positions the biotech for a major oncology expansion

How to Read Applied Materials Earnings: What Signals Move the Stock?

Applied Materials heads into earnings near all-time highs, and whether it beats or dips, the long-term setup still favors the bulls.

Why Microsoft’s Cloud Migrations Matter More Than Its AI Hype

Microsoft’s pullback overlooks the company's Azure migrations, as legacy SQL workloads moving to the cloud may be the real long-term growth driver

IREN Bounces Back: The Market Votes Yes as Big Banks Step In

Major banking partners have validated the aggressive expansion into artificial intelligence infrastructure by underwriting significant growth capital.

Get all your
news in one place.

100's of premium titles.
One news app.

2 Reasons Qualcomm’s Risk/Reward Is Now Red Hot

After a brutal selloff, Qualcomm’s oversold technicals and bullish analyst support are suddenly make its risk/reward profile look unusually attractive.

Offshore Titans: Transocean Buys Valaris for $5.8B

The strategic union of Transocean and Valaris establishes a premier offshore drilling contractor positioned to dominate the deepwater energy market.

BlueBird 6 Unfolds: AST SpaceMobile Unlocks Commercial Growth

AST SpaceMobile confirms the successful unfolding of BlueBird 6 to validate its technology and unlock commercial agreements with global network operators.

Cloudflare: Another AI-Disrupted Stock You Might Want to Buy

Cloudflare is well-positioned to benefit from AI disruption as its business accelerates amid increased agentic traffic across the web.

Shopify Defies Logic: AI Disruption Is a Good Thing

Oh no! AI disrupted Shopify's business and helped it sustain a 30% growth pace, enabling solid cash flow and an increase in the buyback authorization.

These 3 Stocks Just Graduated to the MSCI World Index

The MSCI World Index's February review adds three new companies to the global benchmark as capital flows into space, AI, and aerospace sectors.

Dynatrace’s Earnings Win Makes One Thing Clear: This Software Is Essential

Dynatrace stock surged after the company beat earnings estimates and authorized a new share buyback program, signaling confidence in its long-term value.

1 … 21 22 23 24

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

British Airways

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

358,419 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play